Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| AU565 | Ribociclib | 0.031622777 | 0.7774 | 0.01472 |
| AU565 | Ribociclib | 0.031622777 | 0.7622 | 0.01913 |
| AU565 | Ribociclib | 0.1 | 0.4219 | 0.02154 |
| AU565 | Ribociclib | 0.1 | 0.6402 | 0.01236 |
| AU565 | Ribociclib | 0.1 | 0.5903 | 0.01691 |
| AU565 | Ribociclib | 0.316227766 | 0.5643 | 0.04297 |
| AU565 | Ribociclib | 0.316227766 | 0.4739 | 0.02771 |
| AU565 | Ribociclib | 0.316227766 | 0.5588 | 0.02880 |
| AU565 | Ribociclib | 1.0 | 0.5828 | 0.04089 |
| AU565 | Ribociclib | 1.0 | 0.4803 | 0.05543 |
| AU565 | Ribociclib | 1.0 | 0.4372 | 0.03257 |
| AU565 | Ribociclib | 3.16227766 | 0.3537 | 0.03279 |
| AU565 | Ribociclib | 3.16227766 | 0.5310 | 0.06913 |
| AU565 | Ribociclib | 3.16227766 | 0.4343 | 0.04116 |
| AU565 | Ribociclib | 10.0 | 0.1860 | 0.07713 |
| AU565 | Ribociclib | 10.0 | 0.3065 | 0.04179 |
| AU565 | Ribociclib | 10.0 | 0.2313 | 0.03728 |
| AU565 | LY3023414 | 0.001 | 0.4205 | 0.03178 |
| AU565 | LY3023414 | 0.001 | 0.6746 | 0.04111 |
| AU565 | LY3023414 | 0.001 | 0.5324 | -0.00489 |
| AU565 | LY3023414 | 0.003162278 | 0.4646 | 0.04655 |
| AU565 | LY3023414 | 0.003162278 | 0.6113 | 0.01692 |
| AU565 | LY3023414 | 0.003162278 | 0.3732 | 0.03041 |
| AU565 | LY3023414 | 0.01 | 0.5711 | 0.04419 |
| AU565 | LY3023414 | 0.01 | 0.3658 | 0.06133 |